KAMADA LTD KMDA

Latest FY: 2025 Healthcare Drug Manufacturers - Specialty & Generic
Market Price $7.56
Market Cap $418.80M
P/E Ratio N/A
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↓-98.2% YoY
$180.46M
3-Yr CAGR: 11.7%
Net Income ↑62.3% YoY
$23.47M
Net Margin: 13.0%
Free Cash Flow ↑8.2% YoY
-$7.92M
FCF Yield: -1.89%
EPS (Diluted)
N/A
Basic: N/A
Return on Equity Efficiency
N/A
ROA: 6.2%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (KMDA)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $77.5M $21.4M $-5.0M $0.8M
FY 2017 $102.8M +32.7% $32.1M $7.2M +243.1% $0.4M $-3.8M
FY 2018 $114.5M +11.3% $41.5M $20.3M +183.7% $0.7M $-2.1M +43.1%
FY 2019 $0.2M -99.8% $49.7M $23.0M +13.0% $1.1M $-1.2M +44.3%
FY 2020 $0.3M +15.5% $47.6M $18.6M -19.2% $1.2M $-4.3M -258.2%
FY 2021 $103.6M +39,609.6% $30.3M $-1.9M -110.2% $0.4M $-3.4M +21.6%
FY 2022 $129.3M +24.8% $46.7M $-2.3M -19.8% $0.1M $-3.7M -9.9%
FY 2023 $142.5M +10.2% $55.5M $8.4M +473.1% $1.2M $-4.6M -25.2%
FY 2024 $10,000.0M +6,916.6% $70.0M $14.5M +71.6% $2.1M $-8.6M -86.8%
FY 2025 $180.5M -98.2% $76.4M $23.5M +62.3% $1.9M $-7.9M +8.2%
$

Valuation

Market Price $7.56
Market Cap $418.80M
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio N/A
FCF Yield -1.89%
Dividend Yield N/A
Shares Outstanding 57,686,100
%

Profitability & Margins

Gross Margin 42.34%
Operating Margin 14.54%
Net Margin 13.00%
Return on Equity (ROE) N/A
Return on Assets (ROA) 6.20%
Asset Turnover 0.48x
Revenue 3-Yr CAGR 11.74%
🛡️

Financial Health & Liquidity

Current Ratio N/A
Cash Ratio N/A
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents N/A
Total Debt N/A
Book Value / Share N/A
💧

Cash Flow Efficiency

Operating Cash Flow $1.92M
Capital Expenditures (CapEx) $9.84M
Free Cash Flow -$7.92M
OCF / Revenue 1.06%
FCF / Revenue -4.39%
FCF 3-Yr CAGR N/A
🏷️

Per Share Metrics

EPS (Diluted) N/A
EPS (Basic) N/A
Dividends / Share N/A
Book Value / Share N/A
EPS YoY Growth N/A
🏛️

Balance Sheet (FY 2025)

Total Assets $378.71M
Total Liabilities $1.65M
Stockholders' Equity N/A
Current Assets N/A
Current Liabilities $222.00K